ECJ boost for borderline Products

28-Apr-2009  |  Life Sciences & Healthcare, Patents, Pharmaceutical Law
 


In today's markets it has become common for companies to try to differentiate their products by including substances that could, in certain circumstances, be held to have a metabolic, pharmacological or immunological effect.  Such products are known as "borderline" products and can be difficult to distinguish from products that require marketing authorisations as medicines.  Product classes where borderline products are typically found include food supplements and cosmetics.

For the full article, please click here